Click any of the icons below to view our current NDN clinical trial research studies
If you are interested in participating in research, you can register through Permission to Contact
DFP
Tracking biological and cognitive markers of Alzheimer’s disease to detect disease change.
EVOKE/ EVOKE+
Investigating Semaglutide in People with Early Alzheimer’s Disease.
Probiotic
Investigating the effects of B. Subtilis Bacteria on the microbiome in Parkinson’s Disease.
COBALT
Trialing memantine and cholinesterase inhibitors in Lewy body dementia.
ENROLL-HD
The largest observational study globally for Huntington’s disease.
CAN-PDP
A clinical trial is testing if cannabidiol is a safe and tolerable treatment for reducing symptoms in Parkinson’s disease.
For more information on some of our previous studies please click here
